Document ID: chunk:federal_register_of_legislation:F2022C00581:front:0:p4
Version: federal_register_of_legislation:F2022C00581
Segment Type: other
Provision Reference: 
Character Range: 8819–12082

hypopituitarism;
(16)      having a disorder from the specified list of infiltrative, inflammatory or granulomatous disorders, involving the pituitary gland or hypothalamus, at the time of the clinical worsening of hypopituitarism;
            Note: specified list of infiltrative, inflammatory or granulomatous disorders is defined in the Schedule 1 - Dictionary.
(17)      having infection with human immunodeficiency virus before the clinical worsening of hypopituitarism;
(18)      having a viral, bacterial, fungal or protozoal infection of the pituitary gland, hypothalamus, brain or cerebral meninges, within the five years before the clinical worsening of hypopituitarism;
(19)      having Hantavirus haemorrhagic fever with renal syndrome within the five years before the clinical worsening of hypopituitarism;
            Note: Hantavirus haemorrhagic fever with renal syndrome is defined in the Schedule 1 - Dictionary.
(20)      having moderate to severe traumatic brain injury within the ten years before the clinical worsening of hypopituitarism;
(21)      having a subarachnoid haemorrhage within the ten years before the clinical worsening of hypopituitarism;
(22)      having haemorrhage or ischaemia involving the pituitary gland or hypothalamus within the ten years before the clinical worsening of hypopituitarism;
Note: Haemorrhage or ischaemia of the pituitary gland includes pituitary apoplexy.
(23)      having severe peripartum or postpartum haemorrhage before the clinical worsening of hypopituitarism;
(24)      having surgery involving the pituitary gland, or intracranial surgery, within the ten years before the clinical worsening of hypopituitarism;
(25)      undergoing a course of therapeutic radiation for cancer, where the pituitary or hypothalamus was in the field of radiation, before the clinical  worsening of hypopituitarism;
(26)      having a space occupying lesion that involves, or impinges on, the pituitary gland or hypothalamus at the time of the clinical worsening of hypopituitarism;
(27)      taking an immune checkpoint inhibitor or an interferon within the one year before the clinical worsening of hypopituitarism;
Note: immune checkpoint inhibitor is defined in the Schedule 1 - Dictionary.
(28)      for lymphocytic hypophysitis only, being pregnant within the six months before the clinical worsening of hypopituitarism;
Note: lymphocytic hypophysitis is defined in the Schedule 1 - Dictionary.
(29)      inability to obtain appropriate clinical management for hypopituitarism.
     10           Relationship to service
(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2)          The factors set out in subsections 9(15) to (9)(29) apply only to material contribution to, or aggravation of, hypopituitarism where the person's hypopituitarism was suffered or contracted before or during (but did not arise out of) the person's relevant service.
     11           Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
(1)          if a factor referred to in section 9 applies in relation to a person; and
(2)          that factor refers to an injury